Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands

W. Goettsch, W. Van Pelt, N. Nagelkerke, M. G.R. Hendrix, A. G.M. Buiting, P. L. Petit, L. J.M. Sabbe, A. J.A. Van Griethuysen, A. J. De Neeling

Research output: Contribution to journalArticlepeer-review

223 Citations (Scopus)


In continuous surveillance of routine samples from five Dutch laboratories, we studied resistance to the antibiotics most commonly prescribed for urinary tract infections (UTI) in The Netherlands, namely norfloxacin, amoxycillin, trimethoprim and nitrofurantoin, from 1989 to 1998 in >90 000 Escherichia coli isolates. Resistance to norfloxacin increased from 1.3% in 1989 to 5.8% in 1998. Multiresistance, defined as resistance to norfloxacin and at least two of the other three antibiotics, increased from 0.5% in 1989 to 4.0% in 1998. Multivariate analysis of the norfloxacin resistance demonstrated that this yearly increase (the odds ratio was 1.0 in 1989, 1.6 in 1992, 2.9 in 1995 and 6.1 in 1998) was independent of other determinants of resistance to norfloxacin, such as age, gender and origin of the isolate. Analysis of strata, classified by year, age and gender, demonstrated an association between prescription of fluoroquinolones (defined daily doses per case of UTI) and resistance to norfloxacin in E. coli (P <0.001). There was no significant association with the prescription of nitrofuran derivatives (nitrofurantoin) and trimethoprim with or without sulphamethoxazole. The yearly increase of resistance to fluoroquinolones in E. coli from UTI may stem from increased prescription of fluoroquinolones for UTI. Resistance of E. coli to these agents is likely to increase further as fluoroquinolone use increases in future.

Original languageEnglish
Pages (from-to)223-228
Number of pages6
JournalJournal of Antimicrobial Chemotherapy
Issue number2
Publication statusPublished - 2000
Externally publishedYes

ASJC Scopus subject areas

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands'. Together they form a unique fingerprint.

Cite this